499
Participants
Start Date
August 22, 2013
Primary Completion Date
September 22, 2015
Study Completion Date
August 18, 2022
Dolutegravir/abacavir/lamivudine FDC
Dolutegravir/abacavir/lamivudine FDC tablets, 50 mg/600 mg/300 mg
Atazanavir
Atazanavir capsule 300 mg
Ritonavir
Ritonavir tablet 100 mg
Tenofovir/emtricitabine FDC
Tenofovir/emtricitabine FDC tablet 300 mg/200 mg of FTC
GSK Investigational Site, Mamelodi East
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Lisbon
GSK Investigational Site, Neptune City
GSK Investigational Site, Observatory, Cape Town
GSK Investigational Site, Turin
GSK Investigational Site, Bangkok
GSK Investigational Site, Valhalla
GSK Investigational Site, Nonthaburi
GSK Investigational Site, México
GSK Investigational Site, Buffalo
GSK Investigational Site, Genoa
GSK Investigational Site, Granada
GSK Investigational Site, Allentown
GSK Investigational Site, Philadelphia
GSK Investigational Site, Philadelphia
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Busto Arsizio (VA)
GSK Investigational Site, Bergamo
GSK Investigational Site, Lynchburg
GSK Investigational Site, Brescia
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Charlotte
GSK Investigational Site, (Móstoles) Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Murcia
GSK Investigational Site, Decatur
GSK Investigational Site, Atlanta
GSK Investigational Site, Savannah
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Tampa
GSK Investigational Site, Ft. Pierce
GSK Investigational Site, Seville
GSK Investigational Site, Nantes
GSK Investigational Site, Guadalajara
GSK Investigational Site, Indianapolis
GSK Investigational Site, Detroit
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Omaha
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Fort Worth
GSK Investigational Site, Bellaire
GSK Investigational Site, El Paso
GSK Investigational Site, Phoenix
GSK Investigational Site, Las Vegas
GSK Investigational Site, Beverly Hills
GSK Investigational Site, Bobigny
GSK Investigational Site, Bakersfield
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Smolensk
GSK Investigational Site, Oryol
GSK Investigational Site, Toliyatti
GSK Investigational Site, Augusta
GSK Investigational Site, Springfield
GSK Investigational Site, Newark
GSK Investigational Site, Greensboro
GSK Investigational Site, Ciudad Autónoma de Buenos Aires
GSK Investigational Site, Ciudad de Buenos Aires
GSK Investigational Site, Vancouver
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Amadora
GSK Investigational Site, Porto
GSK Investigational Site, Ponce
GSK Investigational Site, Rio Piedras
GSK Investigational Site, San Juan
GSK Investigational Site, Alicante
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Birmingham
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Sheffield
GSK Investigational Site, Tooting, London
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY